Article

COMING SOON...

Conference|AMCP: The Academy of Managed Care Pharmacy

Our coverage from the Academy of Managed Care Pharmacy's 23rd Annual Meeting & Showcase.

Coverage from the Academy of Managed Care Pharmacy’s 23rd Annual Meeting & Showcase. Our reporting from the conference will include video interviews with thought leaders and coverage of special healthcare reform implementation issues, payment reform, care delivery, coverage requirements, comparative effectiveness research, and more.

Don’t miss our as-they-happen highlights from the nation’s premier event regarding managed care pharmacy.

Related Videos
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Related Content
Ruxolitinib is a kinase inhibitor approved for PV in 2014, and then cGVHD in 2021 | image credit: healthizalife.com
December 10th 2024

ASH 2024 Showcases Real-World Data Demonstrating Efficacy of Ruxolitinib Across Multiple Conditions

Kyle Munz
Two posters presented at the 2024 American Society of Hematology meeting bolster evidence supporting the long-term clinical benefits of ruxolitinib for polycythemia vera and chronic graft-vs-host disease.
Image of Managed Care Cast logo
August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw
At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Monjuvi packaging | Image credit: Incyte
December 10th 2024

Adding Tafasitamab to Standard Follicular Lyphoma Regimen Boosts PFS 57%, Study Finds

Mary Caffrey
The inMIND trial was the first to examine dual targeting of CD19 and CD20 in follicular lymphoma.
Managed Care Cast.
June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia
On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
non-Hodgkin lymphoma | Image Credit: © jarun011-stock.adobe.com
December 9th 2024

Epcoritamab Offers Durable Results in Relapsed B-Cell Lymphoma

Maggie L. Shaw
This pair of posters presented at the 66th American Society of Hematology Annual Meeting & Exposition provides updates on epcoritamab, currently being investigated in the Epcore NHL-1 trial.
Chronic lymphocytic leukemia cells | Image credit: sovova - AdobeStock
December 9th 2024

Epcoritamab Monotherapy Induces Complete Responses in R/R CLL

Gina Mauro
Single-agent, subcutaneous epcoritamab generated deep responses in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL).

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo